Lucertini Giovanni, Rogers Michael Paul, Italiano Enrico Giuseppe, Tarzia Vincenzo, Pradegan Nicola, Gallo Michele, Gerosa Gino
Division of Cardiac Surgery, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padua, Italy.
Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, FL USA.
Indian J Thorac Cardiovasc Surg. 2023 Jul;39(Suppl 1):143-153. doi: 10.1007/s12055-022-01450-y. Epub 2023 Jan 17.
The use of left ventricular assist devices (LVADs) is intended to treat patients with end-stage heart failure. Owing to technological advances, these devices are becoming more durable. However, LVADs may need to be exchanged when complications arise and heart transplantation is not possible. Indications for LVAD exchange (LVADE) include device thrombosis, device infections, and pump component failure. LVADE has historically been associated with a high risk of morbidity and mortality. In this review, we discuss the indications of LVADE, the decisional and technical aspects during surgery, and outcomes.
使用左心室辅助装置(LVAD)旨在治疗终末期心力衰竭患者。由于技术进步,这些装置的耐用性越来越高。然而,当出现并发症且无法进行心脏移植时,可能需要更换LVAD。LVAD更换(LVADE)的指征包括装置血栓形成、装置感染和泵组件故障。从历史上看,LVADE与高发病率和死亡率相关。在本综述中,我们讨论了LVADE的指征、手术中的决策和技术方面以及结果。